241 related articles for article (PubMed ID: 26728511)
1. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer.
Chandler P; Kochupurakkal BS; Alam S; Richardson AL; Soybel DI; Kelleher SL
Mol Cancer; 2016 Jan; 15():2. PubMed ID: 26728511
[TBL] [Abstract][Full Text] [Related]
2. ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells.
Lopez V; Foolad F; Kelleher SL
Cancer Lett; 2011 May; 304(1):41-51. PubMed ID: 21353385
[TBL] [Abstract][Full Text] [Related]
3. Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells.
Bostanci Z; Alam S; Soybel DI; Kelleher SL
Exp Cell Res; 2014 Feb; 321(2):190-200. PubMed ID: 24333596
[TBL] [Abstract][Full Text] [Related]
4. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
5. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells.
Kagara N; Tanaka N; Noguchi S; Hirano T
Cancer Sci; 2007 May; 98(5):692-7. PubMed ID: 17359283
[TBL] [Abstract][Full Text] [Related]
6. Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc.
Lopez V; Kelleher SL
Biochem J; 2009 Jul; 422(1):43-52. PubMed ID: 19496757
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
Natarajan S; Ranganathan M
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
[TBL] [Abstract][Full Text] [Related]
8. Exome Sequencing of SLC30A2 Identifies Novel Loss- and Gain-of-Function Variants Associated with Breast Cell Dysfunction.
Alam S; Hennigar SR; Gallagher C; Soybel DI; Kelleher SL
J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):159-72. PubMed ID: 26293594
[TBL] [Abstract][Full Text] [Related]
9. Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells.
Lopez V; Kelleher SL
Exp Cell Res; 2010 Feb; 316(3):366-75. PubMed ID: 19852955
[TBL] [Abstract][Full Text] [Related]
10. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G; Imbert AM; Jacquemier J; Finetti P; Moreau T; Esterni B; Birnbaum D; Bertucci F; Chabannon C
Breast Cancer Res; 2009; 11(1):R1. PubMed ID: 19123925
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
12. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
13. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells.
Chekhun SV; Lukyanova NY; Shvets YV; Burlaka AP; Buchinska LG
Exp Oncol; 2014 Sep; 36(3):179-83. PubMed ID: 25265351
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of zinc transporter 2 in the blood-CSF barrier following lead exposure.
Fu X; Zeng A; Zheng W; Du Y
Exp Biol Med (Maywood); 2014 Feb; 239(2):202-12. PubMed ID: 24311739
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of two single nucleotide polymorphisms in SLC30A2 (ZnT2): implications for mammary gland function and breast disease in women.
Seo YA; Kelleher SL
Physiol Genomics; 2010 Nov; 42A(4):219-27. PubMed ID: 20858712
[TBL] [Abstract][Full Text] [Related]
16. A histidine-rich motif mediates mitochondrial localization of ZnT2 to modulate mitochondrial function.
Seo YA; Lopez V; Kelleher SL
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1479-89. PubMed ID: 21289295
[TBL] [Abstract][Full Text] [Related]
17. Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation.
Kelleher SL; Velasquez V; Croxford TP; McCormick NH; Lopez V; MacDavid J
J Cell Physiol; 2012 Apr; 227(4):1761-70. PubMed ID: 21702047
[TBL] [Abstract][Full Text] [Related]
18. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
19. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mokbel K; Mansel RE
Clin Cancer Res; 2005 Aug; 11(16):6012-9. PubMed ID: 16115946
[TBL] [Abstract][Full Text] [Related]
20. [Expression of non-secretory CXCL16 and its impact on biological characteristics in breast cancer cell lines].
Fang YY; Lei QQ; Li Y; Chen NY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):522-5, 530. PubMed ID: 24059100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
